Myristoyl Pentapeptide-17 is small peptide. Myristoyl Pentapeptide-17 promotes the delivery of key ingredients for quicker lash growth, thus stimulates the hair growth at the follicle. Myristoyl Pentapeptide-17 effectively promotes the growth of eyelashes. It lengthens and thickens the eyelashes, fortifies the hair and noticeably intensifies eye expression.
CAT No: CPC1655
CAS No:959610-30-1
Synonyms/Alias:Myristoyl Pentapeptide-17;959610-30-1;N-((5S,8S,11S,14S,17S)-1,21-diamino-8-(4-aminobutyl)-5-carbamoyl-14-isobutyl-11-methyl-7,10,13,16-tetraoxo-6,9,12,15-tetraazahenicosan-17-yl)tetradecanamide;N-[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]tetradecanamide;MyristoylPentapeptide-17;Myristoyl Pentapeptide-17?;NFPWMUOQSJXGGZ-ZZTWKDBPSA-N;HY-P0103;JNB61030;AKOS030632924;Myristoyl Pentapeptide -17 Hydrochloride;AC-31939;DA-65737;DS-19757;CS-0017932;C77314;
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.